30 November 2009
Uncommon cutaneous lesions under immunosuppressive therapy
Keiji Sugiura, Mariko Sugiura, Tsuneo Ueki, Norihiko Goto, Akio Katayama, Akira ItoAm J Case Rep 2009; 10:218-220 :: ID: 878285
Abstract
Background: Sarcoidosis may be induced by CD4 T helper cell type-1 T-lymphocytes. Because the action process of cyclosporine inhibits IL-2 mediated T cells, cyclosporine is not sufficient to inhibit sarcoidosis.
Case Report: A 45-year-old man receiving immunosuppressive therapy developed erythema and scales on his face in 2007. Our diagnosis was sarcoidal granulomas based on immunohistopathological findings and no results of polymerase chain reaction for TB or mycobacterium analysis. We treated the patient
using steroid tablets and ointment, which, combined with a pulsed light system for telangiectasia, improved his condition.
Conclusions: This is a common cutaneous disease that occurs after renal transplantation, as has been seen in clinical findings. Although the patient’s conditions developed under immunosuppressive therapy, the treatment had to involve adequate steroids for the treatment of sarcoidosis after renal transplantation. Because cyclosporine was used, the occurrence of sarcoidal granulomas is an uncommon findings result.
Keywords: renal transplantation, Granuloma, sarcoidosis, immunosuppressive therapy, steroid
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






